Lymphoma, Non-Hodgkin

Showing 1 - 25 of 259

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor(CAR) T Cells)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Diffuse Large B Cell Lymphoma
  • CD19-targeted Chimeric Antigen Receptor(CAR) T Cells
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital
Nov 19, 2023

Lymphoma, Non-Hodgkin Trial (JNJ-87801493, JNJ-80948543, JNJ-75348780)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • (no location specified)
Nov 15, 2023

Lymphoma, Non-Hodgkin, Myeloma Multiple Trial (Connected scale "Body Comp Pro" from Withings)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • Myeloma Multiple
  • Connected scale "Body Comp Pro" from Withings
  • (no location specified)
Nov 9, 2023

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

Leukemia, Acute Lymphoblastic, Lymphoma, Non-Hodgkin Trial in Ribeirao Preto (CART-19)

Not yet recruiting
  • Leukemia, Acute Lymphoblastic
  • Lymphoma, Non-Hodgkin
  • CART-19
  • Ribeirao Preto, Sao Paulo, Brazil
    Ribeirao Preto School of Medicine, University of Sao Paulo
Oct 23, 2023

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell Trial in United Kingdom (ALETA-001)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • +4 more
  • Birmingham, United Kingdom
  • +5 more
Sep 18, 2023

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

Stem Cell Transplantation, MDS, Leukemia, Myeloid, Acute Trial in Miami (Mindfulness-based Music Therapy (MBMT), Mindfulness

Not yet recruiting
  • Stem Cell Transplantation
  • +4 more
  • Mindfulness-based Music Therapy (MBMT)
  • Mindfulness Meditation (MM)
  • Miami, Florida
    University of Miami
Aug 1, 2023

Lymphoma, Non-Hodgkin Trial in China (DZD8586)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Beijing, Beijing, China
  • +5 more
Apr 25, 2023

Lymphoma, Non-Hodgkin Trial in Perth (DZD8586)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • Perth, Western Australia, Australia
    Linear Clinical Research Ltd
Apr 20, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Miltenyi CliniMACS Prodigy ® system
  • (no location specified)
Mar 23, 2023

People Living With HIV Treated With CD19-directed CAR T Cell

Active, not recruiting
  • Leukemia
  • +9 more
    • Philadelphia, Pennsylvania
      Pennsylvania Hospital
    Mar 29, 2023

    HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (Pfizer Bivalent COVID-19 Vaccine, Moderna Bivalent mRNA

    Recruiting
    • HIV
    • +5 more
    • Pfizer Bivalent COVID-19 Vaccine
    • Moderna Bivalent mRNA vaccine
    • Melbourne, Victoria, Australia
      Alfred Health
    Jan 31, 2023

    Lymphoma, Non-Hodgkin Trial in Worldwide (Copanlisib (BAY80-6946), Placebo, Rituximab)

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • Copanlisib (BAY80-6946)
    • +7 more
    • Chandler, Arizona
    • +199 more
    Jan 31, 2023

    Lymphoma, Non-Hodgkin Trial in Worldwide (RO7227166, Obinutuzumab, Glofitamab)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Pasadena, California
    • +14 more
    Jan 30, 2023

    Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

    Completed
    • Lymphoid Leukemia
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin
    Jan 30, 2023

    Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States

    Completed
    • Non-Hodgkin's Lymphoma, Relapsed
    • +8 more
    • PBCAR20A
    • +2 more
    • Duarte, California
    • +4 more
    Jan 4, 2023

    Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-75348780)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Birmingham, Alabama
    • +43 more
    Jan 27, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin Trial in Worldwide (JNJ-67856633, Ibrutinib)

    Active, not recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Lymphoma, Non-Hodgkin
    • Copenhagen, Denmark
    • +9 more
    Jan 27, 2023

    Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-64264681)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • New York, New York
    • +15 more
    Jan 27, 2023

    Lymphoma, Non-Hodgkin Trial in Worldwide (Fludarabine, Cyclophosphamide, JCAR017)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Santa Monica, California
    • +36 more
    Jan 25, 2023

    Lymphoma, Non-Hodgkin Trial in Worldwide (CC-99282, Rituximab, Obinutuzumab)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Los Angeles, California
    • +86 more
    Jan 23, 2023

    Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • New York, New York
      Weill Cornell Medicine/NewYork-Presberteryian Hospital
    Jan 18, 2023

    Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • Stem cell infusion
    • +5 more
    • Saint Louis, Missouri
      Washington University
    Jan 17, 2023

    Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (JCAR017, Durvalumab,

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • JCAR017
    • +7 more
    • Duarte, California
    • +17 more
    Jan 13, 2023